What is Geroderma osteodysplastica?
Geroderma osteodysplastica (GO), also known as Walt Disney dwarfism or gerodermia osteodysplastica, is a rare autosomal recessive connective tissue disorder characterized by the combination of prematurely aged (wrinkled) skin and skeletal abnormalities. The condition is caused by mutations in the GORAB gene (also known as SCYL1BP1) on chromosome 1q24, which encodes a protein involved in Golgi apparatus function and protein glycosylation. The disease primarily affects the skin and skeletal system. Skin manifestations include lax, wrinkled skin that gives patients a prematurely aged appearance, most prominently on the dorsum of the hands and feet, as well as the face and abdomen. Skeletal features include severe osteoporosis leading to frequent fractures, platyspondyly (flattened vertebral bodies), metaphyseal abnormalities of long bones, and short stature. Facial features may include a small jaw (micrognathia), midface hypoplasia, and a beaked nose. Joint hypermobility or laxity is also commonly observed. Some patients may develop kyphoscoliosis and wormian bones in the skull. There is currently no cure or disease-specific treatment for geroderma osteodysplastica. Management is supportive and multidisciplinary, focusing on monitoring and treating osteoporosis (bisphosphonates have been used in some cases), orthopedic management of fractures and skeletal deformities, and dermatological care. Genetic counseling is recommended for affected families. The condition is extremely rare, with fewer than 50 cases reported in the medical literature, and has been described in several consanguineous families, particularly of Middle Eastern and Mediterranean descent.
Clinical phenotype terms— hover any for plain English:
- Vertebral compression fractureHP:0002953
- Beaking of vertebral bodiesHP:0004568
- Biconcave vertebral bodiesHP:0004586
- Abnormal bone ossificationHP:0011849
- Inheritance
- Autosomal recessive
- Passed on when both parents carry the same gene change; often skips generations
- Age of Onset
- Neonatal
- Begins at or shortly after birth (first 4 weeks)
Treatments
Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly
No FDA-approved treatments are currently listed for Geroderma osteodysplastica.
View clinical trials →Clinical Trials
View all trials with filters →Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest
No actively recruiting trials found for Geroderma osteodysplastica at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)
No specialists are currently listed for Geroderma osteodysplastica.
Treatment Centers
8 centersSource: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months
Children's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to Geroderma osteodysplastica.
Community
No community posts yet. Be the first to share your experience with Geroderma osteodysplastica.
Start the conversation →Latest news about Geroderma osteodysplastica
Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC
No recent news articles for Geroderma osteodysplastica.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Geroderma osteodysplastica
What is Geroderma osteodysplastica?
Geroderma osteodysplastica (GO), also known as Walt Disney dwarfism or gerodermia osteodysplastica, is a rare autosomal recessive connective tissue disorder characterized by the combination of prematurely aged (wrinkled) skin and skeletal abnormalities. The condition is caused by mutations in the GORAB gene (also known as SCYL1BP1) on chromosome 1q24, which encodes a protein involved in Golgi apparatus function and protein glycosylation. The disease primarily affects the skin and skeletal system. Skin manifestations include lax, wrinkled skin that gives patients a prematurely aged appearance,
How is Geroderma osteodysplastica inherited?
Geroderma osteodysplastica follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Geroderma osteodysplastica typically begin?
Typical onset of Geroderma osteodysplastica is neonatal. Age of onset can vary across affected individuals.
Frequently asked questions about Geroderma osteodysplastica
Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.
What is Geroderma osteodysplastica?
Geroderma osteodysplastica is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:2078, OMIM 231070). It is typically inherited as autosomal recessive. Age of onset is generally neonatal. For verified primary sources, see the UniteRare Geroderma osteodysplastica page.
How is Geroderma osteodysplastica inherited?
Geroderma osteodysplastica follows autosomal recessive inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.
Are there FDA-approved treatments for Geroderma osteodysplastica?
Approved treatments for Geroderma osteodysplastica are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.
Are there clinical trials for Geroderma osteodysplastica?
Active clinical trials for Geroderma osteodysplastica are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.
How do I find a specialist for Geroderma osteodysplastica?
Verified Geroderma osteodysplastica specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.
See full Geroderma osteodysplastica page for complete clinical details, sources, and verified-specialist listings.
Cite this page
Select a citation format above to view and copy.